Tango Therapeutics, INC. (TNGX) SEC Filings — 2025
12 SEC filings for Tango Therapeutics, INC. (TNGX) in 2025.
Filings
- Tango Therapeutics Enters and Terminates Agreements — 8-K · Nov 21, 2025
- Tango Therapeutics' Cash Dips, WuXi AppTec Legislation Looms — 10-Q · Nov 4, 2025
- Tango Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Oct 24, 2025
- Tango Therapeutics Files 8-K — 8-K · Oct 23, 2025
- Tango Therapeutics Announces CMO Departure, Director Changes — 8-K · Aug 25, 2025
- Tango Therapeutics' Q2 Net Loss Widens to $59.8M Amid Soaring R&D Costs — 10-Q · Aug 5, 2025
- Tango Therapeutics Files 8-K on Shareholder Votes and Bylaws — 8-K · Jun 6, 2025
- Tango Therapeutics Files Q1 2025 10-Q — 10-Q · May 12, 2025
- Tango Therapeutics Files Proxy Materials for 2025 Meeting — DEFA14A · Apr 22, 2025
- Tango Therapeutics Executive Compensation Details Released — DEF 14A · Apr 21, 2025
- Tango Therapeutics Files 2024 10-K — 10-K · Feb 27, 2025
- Tango Therapeutics, INC. 8-K Filing — 8-K · Jan 13, 2025